Nature Genetics,
Journal Year:
2022,
Volume and Issue:
55(1), P. 66 - 77
Published: Dec. 21, 2022
Abstract
Single-cell
transcriptomics
has
allowed
unprecedented
resolution
of
cell
types/states
in
the
human
lung,
but
their
spatial
context
is
less
well
defined.
To
(re)define
tissue
architecture
lung
and
airways,
we
profiled
five
proximal-to-distal
locations
healthy
lungs
depth
using
multi-omic
single
cell/nuclei
(queryable
at
lungcellatlas.org
).
Using
computational
data
integration
analysis,
extend
beyond
suspension
paradigm
discover
macro
micro-anatomical
compartments
including
previously
unannotated
types
epithelial,
vascular,
stromal
nerve
bundle
micro-environments.
We
identify
implicate
peribronchial
fibroblasts
disease.
Importantly,
validate
a
survival
niche
for
IgA
plasma
cells
airway
submucosal
glands
(SMG).
show
that
gland
epithelial
recruit
B
cells,
promote
longevity
antibody
secretion
locally
through
expression
CCL28,
APRIL
IL-6.
This
new
‘gland-associated
immune
niche’
implications
respiratory
health.
Cell,
Journal Year:
2022,
Volume and Issue:
185(5), P. 881 - 895.e20
Published: Jan. 25, 2022
Post-acute
sequelae
of
COVID-19
(PASC)
represent
an
emerging
global
crisis.
However,
quantifiable
risk
factors
for
PASC
and
their
biological
associations
are
poorly
resolved.
We
executed
a
deep
multi-omic,
longitudinal
investigation
309
patients
from
initial
diagnosis
to
convalescence
(2-3
months
later),
integrated
with
clinical
data
patient-reported
symptoms.
resolved
four
PASC-anticipating
at
the
time
diagnosis:
type
2
diabetes,
SARS-CoV-2
RNAemia,
Epstein-Barr
virus
viremia,
specific
auto-antibodies.
In
gastrointestinal
PASC,
SARS-CoV-2-specific
CMV-specific
CD8+
T
cells
exhibited
unique
dynamics
during
recovery
COVID-19.
Analysis
symptom-associated
immunological
signatures
revealed
coordinated
immunity
polarization
into
endotypes,
exhibiting
divergent
acute
severity
PASC.
find
that
between
diminish
over
time,
leading
distinct
convalescent
immune
states.
Detectability
most
emphasizes
importance
early
disease
measurements
understanding
emergent
chronic
conditions
suggests
treatment
strategies.
European Journal of Immunology,
Journal Year:
2021,
Volume and Issue:
51(12), P. 2708 - 3145
Published: Dec. 1, 2021
Abstract
The
third
edition
of
Flow
Cytometry
Guidelines
provides
the
key
aspects
to
consider
when
performing
flow
cytometry
experiments
and
includes
comprehensive
sections
describing
phenotypes
functional
assays
all
major
human
murine
immune
cell
subsets.
Notably,
contain
helpful
tables
highlighting
differences
between
cells.
Another
useful
feature
this
is
analysis
clinical
samples
with
examples
applications
in
context
autoimmune
diseases,
cancers
as
well
acute
chronic
infectious
diseases.
Furthermore,
there
are
detailing
tips,
tricks
pitfalls
avoid.
All
written
peer‐reviewed
by
leading
experts
immunologists,
making
an
essential
state‐of‐the‐art
handbook
for
basic
researchers.
Immunity,
Journal Year:
2021,
Volume and Issue:
54(6), P. 1257 - 1275.e8
Published: May 16, 2021
The
kinetics
of
the
immune
changes
in
COVID-19
across
severity
groups
have
not
been
rigorously
assessed.
Using
immunophenotyping,
RNA
sequencing,
and
serum
cytokine
analysis,
we
analyzed
serial
samples
from
207
SARS-CoV2-infected
individuals
with
a
range
disease
severities
over
12
weeks
symptom
onset.
An
early
robust
bystander
CD8+
T
cell
response,
without
systemic
inflammation,
characterized
asymptomatic
or
mild
disease.
Hospitalized
had
delayed
responses
inflammation
that
was
already
evident
near
onset,
indicating
immunopathology
may
be
inevitable
some
individuals.
Viral
load
did
correlate
this
pathological
response
but
subsequent
severity.
Immune
recovery
is
complex,
profound
persistent
cellular
abnormalities
severe
correlating
altered
inflammatory
responses,
signatures
associated
increased
oxidative
phosphorylation
replacing
those
driven
by
cytokines
tumor
necrosis
factor
(TNF)
interleukin
(IL)-6.
These
late
immunometabolic
defects
clinical
implications.
Cell,
Journal Year:
2021,
Volume and Issue:
184(18), P. 4713 - 4733.e22
Published: July 23, 2021
SARS-CoV-2
infection
can
cause
severe
respiratory
COVID-19.
However,
many
individuals
present
with
isolated
upper
symptoms,
suggesting
potential
to
constrain
viral
pathology
the
nasopharynx.
Which
cells
primarily
targets
and
how
influences
epithelium
remains
incompletely
understood.
We
performed
scRNA-seq
on
nasopharyngeal
swabs
from
58
healthy
COVID-19
participants.
During
COVID-19,
we
observe
expansion
of
secretory,
loss
ciliated,
epithelial
cell
repopulation
via
deuterosomal
expansion.
In
mild
moderate
express
anti-viral/interferon-responsive
genes,
while
in
have
muted
anti-viral
responses
despite
equivalent
loads.
RNA
Cell,
Journal Year:
2022,
Volume and Issue:
185(5), P. 916 - 938.e58
Published: Jan. 21, 2022
Treatment
of
severe
COVID-19
is
currently
limited
by
clinical
heterogeneity
and
incomplete
description
specific
immune
biomarkers.
We
present
here
a
comprehensive
multi-omic
blood
atlas
for
patients
with
varying
severity
in
an
integrated
comparison
influenza
sepsis
versus
healthy
volunteers.
identify
signatures
correlates
host
response.
Hallmarks
disease
involved
cells,
their
inflammatory
mediators
networks,
including
progenitor
cells
myeloid
lymphocyte
subsets,
features
the
repertoire,
acute
phase
response,
metabolism,
coagulation.
Persisting
activation
involving
AP-1/p38MAPK
was
feature
COVID-19.
The
plasma
proteome
enabled
sub-phenotyping
into
patient
clusters,
predictive
outcome.
Systems-based
integrative
analyses
tensor
matrix
decomposition
all
modalities
revealed
groupings
linked
specificity
compared
to
sepsis.
Our
approach
will
support
future
drug
development,
trial
design,
personalized
medicine
approaches